Inspiring entrepreneur and innovative researcher: Dr. Merel Boers is co-founder and CEO of Nicolab.

Improve patient outcomes while reducing hospital costs.

Dr. Michael Hill shares with us the potential impact of the ESCAPE-NA1 trial.

As the year draws to a close, we want to reflect on some highlights and milestones we have reached during an unusual and challenging year.

Expert discussion between Dr. Bart Emmer and Renan Sales Barros on “How Cloud-based AI Solutions are Transforming Stroke Care.”

Thanks to its FDA clearance, after Australia and Europe, StrokeViewer also arrives in the US.

Dr. Ludo Beenen feels the stroke workflow will be different following COVID-19.

Prof. Bram van Ginneken talks about the current and future impact of AI in healthcare.

Dr. Fabien Scalzo is excited to use machine learning to save lives while understanding how they work.

Dr. Albert Yoo shares insights into the TESLA trial: a potentially pivotal trial in stroke care.

Nicolab has been selected for Techleap.nl Rise program, the showcase for future unicorns.

ICOVAI consortium is a not-for-profit initiative to fight against COVID-19.